Skip to main content

Part of the book series: Current Clinical Neurology ((CCNEU))

Abstract

Schizophrenia affects approx 1% of the population. In the United States, somewhere between 2 and 4 million people have schizophrenia (1). In addition, schizophrenia is widely considered to be the most severe and disabling of the psychiatric disorders. It is estimated that approx 30% of all hospital beds in the United States are occupied by persons with schizophrenia. In the Epidemiologic Catchment Area Study (ECA), the largest epidemiological study of psychiatric disorders, the lifetime prevalence of schizophrenic disorders (e.g., schizophrenia, schizoaffective disorder, delusional disorder) was 1.4%. However, in institutional settings, this prevalence was much higher; in mental hospitals the prevalence was 20.4%, in nursing homes it was 3.8%, and in prisons it was 6.7%. The prevalence of schizophrenia is highest in people aged 30–44 (2.3%) and lowest among those over age 65. Women were slightly more likely to have schizophrenia than men. African Americans had the highest rate at 2.1%, with Caucasians at 1.4%, and Latinos at 0.8% (2).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Keith SJ, Regier DA, Rae DS. Schizophrenic disorders in psychiatric disorders in America. In: Robins LN, Regier DA, eds. The Epidemiologic Catchment Area Study. New York: Free Press; 1991.

    Google Scholar 

  2. Robins LN, Regier DA. Psychiatric disorders in America. In: Robins LN, Regier DA, eds. The Epidemiologic Catchment Area Study. New York: Free Press; 1991.

    Google Scholar 

  3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, revised. Washington DC: Amer Psychiatric Pub; 2000.

    Google Scholar 

  4. Schiffman J, Walker E, Ekstrom M, Schulsinger F, Sorensen H, Mednick S. Childhood videotaped social and neuromotor precursors of schizophrenia: a prospective investigation. Am J Psychiatry 2004;161:2021–2027.

    Article  PubMed  Google Scholar 

  5. Usall J, Haro JM, Ochoa S, Marquez M, Araya S. Needs of patients with schizophrenia group: influence of gender on social outcome in schizophrenia. Acta Psychiatr Scand 2002;106:337–342.

    Article  PubMed  CAS  Google Scholar 

  6. Folsom D, Jeste DV. Schizophrenia in homeless persons: a systematic review of the literature. Acta Psychiatr Scand 2002;104:1–10.

    Google Scholar 

  7. Folsom DP, Hawthorne W, Lindamer L, et al. Homelessness among patients with serious mental illness in a large public mental health system: prevalence, risk factors, and utilization of mental healthcare services among 10,340 patients. Am J Psychiatry 2005 162:370–376.

    Article  PubMed  Google Scholar 

  8. Norquist GS, Narrow WE. Schizophrenia: epidemiology. In: Kaplan A, Saddock BJ, eds. Schizophrenia. New York: Lippincott, Williams & Wilkins, 2004.

    Google Scholar 

  9. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington DC: Amer Psychiatric Pub;1994.

    Google Scholar 

  10. Green MF, Kern RS, Braff DL, Mintz J. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the “right stuff?” Schizophr Bull 2000;26:119–136.

    PubMed  CAS  Google Scholar 

  11. Evans JD, Heaton RK, Paulsen JS, Palmer BW, Patterson T, Jeste DV. The relationship of neuropsychological abilities to specific domains of functional capacity in older schizophrenia patients. Biol Psychiatry 2003;53:422–430.

    Article  PubMed  Google Scholar 

  12. Eyler LT, Jeste DV. Schizophrenia in Encyclopedia of the Human Brain, Ramchandran VS, ed.. San Diego: Academic Press; 2002.

    Google Scholar 

  13. Freedman R. Schizophrenia. N Engl J Med 2003;349:1738–1749.

    Article  PubMed  CAS  Google Scholar 

  14. Tamminga CA, Thaker GK, Buchanan R, et al. Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome. Arch Gen Psychiatry 1992;49:522–530.

    PubMed  CAS  Google Scholar 

  15. Krystal JH, D’Souza DC, Sanacora G, Goddard AW, Charney DS. Current perspectives on the pathophysiology of schizophrenia, depression, and anxiety disorders. Med Clin North Am 2001;85:559–577.

    Article  PubMed  CAS  Google Scholar 

  16. Heaton RK, Gladsjo JA, Palmer BW, Kuck J, Marcotte TD, Jeste DV. Stability and course of neuropsychological deficits in schizophrenia. Arch Gen Psychiatry 2001;58:24–32.

    Article  PubMed  CAS  Google Scholar 

  17. Jeste DV, Twamley EW, Eyler Zorrilla LT, Golshan S, Patterson TL, Palmer BW. Aging and outcome in schizophrenia. Acta Psychiatr Scand 2003;107:336–343.

    Article  PubMed  CAS  Google Scholar 

  18. Auslander LA, Jeste DV. Sustained remission of schizophrenia among community-dwelling older outpatients. Am J Psychiatry 2004;161:1490–1493.

    Article  PubMed  Google Scholar 

  19. Schubert EW, McNeil TF. Prospective study of neurological abnormalities in offspring of women with psychosis: birth to adulthood. Am J Psychiatry 2004;161:1030–1037.

    Article  PubMed  Google Scholar 

  20. Folsom DP, Nayak GV, Jeste DV. Antipsychotic medications and the elderly. Primary Psychiatry 2004;11:47–50.

    Google Scholar 

  21. McClure FS, Gladsjo JA, Jeste DV. Late onset psychosis: clinical, research, and ethical considerations [clinical conference]. Am J Psychiatry 1999;156:935–940.

    PubMed  CAS  Google Scholar 

  22. American Psychiatric Association. Practice guidelines for the treatment of patients with schizophrenia. American Psychiatric Association 1997;154:1–63.

    Google Scholar 

  23. Fenton WS, McGlashan TH. Natural history of schizophrenia subtypes. II: Positive and negative symptoms and longterm course. Arch Gen Psychiatry 1991;48:978–986.

    PubMed  CAS  Google Scholar 

  24. Breier A, Schreiber JL, Dyer J, Pickar D. National Institute of Mental Health longitudinal study of chronic schizophrenia: prognosis and predictors of outcome. Arch Gen Psychiatry 1991;48:239–246.

    PubMed  CAS  Google Scholar 

  25. Dolder CR, Lacro JP, Dunn LB, Jeste DV. Antipsychotic medication adherence: is there a difference between typical and atypical agents? Am J Psychiatry 2002;159:103–108.

    Article  PubMed  Google Scholar 

  26. Patterson TL, McKibbin CL, Taylor MJ, et al. Functional Adaptation Skills Training (FAST): a pilot psychosocial intervention study in middle-aged and older patients with chronic psychotic disorders. Am J Geriatr Psychiatry 2003;11:17–23.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Folsom, D.P., Fleisher, A.S., Depp, C.A. (2006). Schizophrenia. In: Jests, D.V., Friedman, J.H. (eds) Psychiatry for Neurologists. Current Clinical Neurology. Humana Press. https://doi.org/10.1007/978-1-59259-960-8_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-960-8_6

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-483-8

  • Online ISBN: 978-1-59259-960-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics